Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer
Clinical trial NCT02147990 · TERMINATED
Trial details
- NCT number
- NCT02147990
- Sponsor
- Clovis Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-16
- Primary completion
- 2019-07-30
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.